Pretreatment prognostic factors in patients with early-stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 4, 2006, Pages 1112-1119

  Jeremić, Branislav ^a   Milicić, Biljana ^a   Dagović, Aleksandar ^a   Acimović, Ljubisa ^a   Milisavljević, Slobodan ^a  

^a University Hospital   (Yugoslavia)

Author keywords

Early stage; Hyperfractionation; Non small cell lung cancer; Prognostic factors; Radiation therapy

Indexed keywords

CELLS; DISEASES; DOSIMETRY; HISTOLOGY; SURGERY; TUMORS;

EARLY STAGE; HYPERFRACTIONATION; NON-SMALL-CELL LUNG CANCER; PROGNOSTIC FACTORS;

RADIOTHERAPY;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33745208454     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.044     Document Type: Article

References (54)

1. Ginsberg R.J., Rubinstein L., and Lung Cancer Study Group. A randomised study of lobectomy versus limited resection for patients with T1N0 non-small cell lung cancer. Ann Thorac Surg 60 (1995) 908-913
2. Martini N., and Beattie E. Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg 74 (1977) 499-505
3. Mountain C.F. A new international staging system for lung cancer. Chest 89 (1986) 225S-233S
4. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
5. Naruke T., Goya T., Tsuchiya R., et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96 (1988) 440-447
6. Hicks R.J., Kalff V., MacManus M.P., et al. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 42 (2001) 1596-1604
7. Erdi Y.E., Rosenzweig K., Erdi A.K., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62 (2002) 51-60
8. Hicks R.J., Kalff V., MacManus M.P., et al. The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy. Impact on management and prognostic stratification. J Nucl Med 42 (2001) 1605-1613
9. Hara R., Itami J., Kondo T., et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 63 (2002) 159-163
10. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52 (2002) 1041-1046
11. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma. Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
12. Zimmermann F., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48 (2005) 107-114
13. Cheung P.C.F., Mackillop W.J., Dixon P., et al. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 703-710
14. Cooper J.F.D., Pearson F.G., Todd T.R.J., et al. Radiotherapy alone for patients with operable carcinoma of the lung. Chest (1985) 289-292
15. Coy P., and Kennelly G.M. The role of curative radiotherapy in the treatment of lung cancer. Cancer 45 (1980) 698-702
16. Dosoretz D.E., Katin M.J., Blitzer P.H., et al. Radiation therapy in the management of medically inoperable carcinoma of the lung. Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 25 (1992) 3-9
17. Dosoretz D.E., Galmarini D., Rubenstein J.H., et al. Local control in medically inoperable lung cancer. An analysis of its importance in outcome and factors determining the probability of tumour eradication. Int J Radiat Oncol Biol Phys 27 (1993) 507-516
18. Firat S., Bousamra M., Gore E., et al. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 1047-1057
19. Furuta M., Hayakawa K., Katano S., et al. Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older. Jpn J Clin Oncol 26 (1996) 95-98
20. Gauden S., Ramsay J., and Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108 (1995) 1278-1282
21. Gauden S.J., and Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer 32 (2001) 71-79
22. Graham P.H., Gebski V.J., and Langlands A.O. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 31 (1995) 261-266
23. Haffty B.G., Goldberg N.B., Gerstley J., et al. Results of radical radiation therapy in clinical Stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 15 (1988) 69-73
24. Hayakawa K., Mitsuhashi N., Nakajima N., et al. Radiation therapy for stage III epidermoid carcinoma of the lung. Lung Cancer 8 (1992) 213-224
25. Hayakawa K., Mitsuhashi N., Saito Y., et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26 (1999) 137-142
26. Hayakawa K., Mitsuhashi N., Katano S., et al. High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 32 (2001) 81-88
27. Jeremic B., Shibamoto Y., Acimovic L.J., et al. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 38 (1997) 521-525
28. Jeremic B., Shibamoto Y., Acimovic L.J., et al. Hyperfractionated radiotherapy for clinical stage II nonsmall cell lung cancer. Radiother Oncol 51 (1999) 141-145
29. Kaskowitz L., Graham M.V., Emami B., et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27 (1993) 517-523
30. Krol A.D.G., Aussems P., Noordijk E.M., et al. Local irradiation alone for peripheral stage I lung cancer. Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 34 (1996) 297-302
31. Kupelian P.A., Komaki R., and Allen P. Prognostic factors in the treatment of node- negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36 (1996) 607-613
32. Morita K., Fuwa N., Suzuki Y., et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I. Retrospective analysis of 149 patients. Radiother Oncol 42 (1997) 31-36
33. Morrison R., Delley T.J., and Cleland W.P. The treatment of carcinoma of the bronchus. A clinical trial to compare surgery and supervoltage radiotherapy. Lancet I (1963) 683-684
34. Noordijk E.M., vd Poest Clement E., Hermans J., et al. Radiotherapy as an alternative to surgery in elderly patients with respectable lung cancer. Radiother Oncol 13 (1988) 83-89
35. Ono R., Egawa S., Suemasu K., et al. Radiotherapy in inoperable stage I lung cancer. Jpn J Clin Oncol 21 (1991) 125-128
36. Rosenthal S.A., Curran Jr. W.J., Herbert S.H., et al. Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease). Cancer 70 (1992) 3410-3417
37. Sandler H.M., Curran Jr. W.J., and Turrisi III A.T. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 19 (1990) 9-13
38. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer. The Duke experience. Int J Radiat Oncol Biol Phys 40 (1998) 149-154
39. Smart J. Can lung cancer be cured by irradiation alone?. JAMA 195 (1966) 1034-1035
40. Slotman B.J., and Karim A.B.M.F. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 29 (1994) 33-37
41. 0) non-small cell lung cancer. Radiother Oncol 41 (1996) 41-44
42. Talton B.M., Constable W.C., and Kersh C.R. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 19 (1990) 15-21
43. Zhang H.X., Yin W.B., Zhang L.J., et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 14 (1989) 89-94
44. McGarry R.C., Song G., des Rosiers P., et al. Observation-only management of early stage, medically inoperable lung cancer. Poor outcome. Chest 121 (2002) 1155-1158
45. Jeremic B., Classen J., and Bamberg M. Observation-only management of early stage, medically inoperable lung cancer. Do not do that-a loud and a clear radiotherapeutic point of view!. Chest 123 (2003) 313-314
46. Henschke C.I., Wisnivesky J.P., Yankelevitz D.F., et al. Small stage I cancers of the lung. Genuineness and curability. Lung Cancer 39 (2003) 327-330
47. Glatstein E., and Makuch R.W. Illusion and reality. Practical pitfalls in interpreting clinical trials. J Clin Oncol 2 (1984) 488-497
48. Simon R. Importance of prognostic factors in cancer clinical trials. Cancer Treat Rep 68 (1984) 185-192
49. Curran Jr. W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85 (1993) 704-710
50. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
51. Lagerwaard F.J., Senan S., van Meerbeeck J.P., et al. Has 3-D conformal radiotherapy (3D-CRT) improved local tumour control for stage I non-small cell lung cancer?. Radiother Oncol 63 (2002) 151-157
52. Cox J.D., Scott C.B., Byhardt R.W., et al. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCLC). Analysis of Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 43 (1999) 505-509
53. Jeremic B., Classen J., and Bamberg M. Radiation therapy alone in technically operable, medically inoperable early stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 119-130
54. Zimmermann F.B., Bamberg M., Molls M., and Jeremic B. Radiation therapy alone in early stage non-small-cell lung cancer. Semin Surg Oncol 21 (2003) 91-97